malignant glioma

You have access
Immune Phenotype Correlates With Survival in Patients With GBM Treated With Standard Temozolomide-based Therapy and Immunotherapy
MARKOS ANTONOPOULOS, STEFAAN W. VAN GOOL, DIMITRA DIONYSIOU, NORBERT GRAF and GEORGIOS STAMATAKOS

Anticancer Research April 2019, 39 (4) 2043-2051; DOI: https://doi.org/10.21873/anticanres.13315
You have access
A Retrospective Evaluation of Bevacizumab Treatment in Patients with Progressive Malignant Glioma in Northern Sweden
MARIA SANDSTRÖM, MARIA LAUDIUS, THOMAS LINDQVIST, THOMAS ASKLUND and MIKAEL JOHANSSON

Anticancer Research April 2017, 37 (4) 1869-1874;
You have access
Safety and Tolerance of D,L-Methadone in Combination with Chemotherapy in Patients with Glioma
JULIA ONKEN, CLAUDIA FRIESEN, PETER VAJKOCZY and MARTIN MISCH

Anticancer Research March 2017, 37 (3) 1227-1235;
You have access
Cell Membrane Perforation with Photosensitizer and a Brush-shaped Soft-polymer Sheet Using a Malignant Glioma Cell Line
TOSHIAKI TACHIBANA, YUTA SUZUKI, KOUKI FUJIOKA, KEIICHI IKEDA, YURIKO INOUE, YOSHIFUMI TADA, TAKASHI KEI SAITO and YOSHINOBU MANOME

Anticancer Research November 2015, 35 (11) 6069-6074;
You have access
Fighting Fire with Fire: The Revival of Thermotherapy for Gliomas
WILLIAM LEE TITSWORTH, GREG J.A. MURAD, BRIAN L. HOH and MARYAM RAHMAN

Anticancer Research February 2014, 34 (2) 565-574;
You have access
Integrin Inhibitor Cilengitide for the Treatment of Glioblastoma: A Brief Overview of Current Clinical Results
CLAUDIA SCARINGI, GIUSEPPE MINNITI, PAOLA CAPORELLO and RICCARDO MAURIZI ENRICI

Anticancer Research October 2012, 32 (10) 4213-4223;

Main menu

User menu

Search

malignant glioma